Natural Metabolites from Clinacanthus nutans as Promising SARS-CoV-2 Main Protease Inhibitors: Insights from Molecular Docking and Dynamics Simulations
Abstract
Structure-based drug design against SARS-CoV-2 main protease (Mpro) was enabled by the availability of its crystal structure (PDB ID: 6LU7). In this study, metabolites from Clinacanthus nutans were computationally evaluated as potential Mpro inhibitors using validated molecular docking and molecular dynamics (MD) approaches. Native ligand re-docking produced an RMSD of 1.329 Å, confirming the reliability of the docking setup. Among the tested compounds, vitexin demonstrated a favorable binding affinity in docking analysis, indicating its potential for interaction within the active site of Mpro. However, further evaluation using 100 ns MD simulations and MM/PBSA free energy calculations revealed that, although the vitexin–Mpro complex remained relatively stable, the native ligand exhibited superior thermodynamic stability and binding free energy. Overall, vitexin shows promising binding characteristics as a natural compound targeting Mpro, but it does not surpass the native ligand in terms of overall binding stability. These findings suggest that vitexin may serve as a potential lead compound, warranting further optimization and experimental validation.
Keywords
References
- 1. WHO. Coronavirus disease (COVID-2019) situation reports. World Heal Organ. 2020;
- 2. Rut W, Groborz K, Zhang L, Sun X, Zmudzinski M, Pawlik B, et al. SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021 Feb 22;17(2):222–8. Available from:
. - 3. Reiner Ž, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T, et al. Statins and the COVID-19 main protease: In silico evidence on direct interaction. Arch Med Sci. 2020;16(3):490–6. Available from:
. - 4. Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. J Biomol Struct Dyn. 2020 May 5;39(9):3092–8. Available from:
. - 5. Sinha SK, Shakya A, Prasad SK, Singh S, Gurav NS, Prasad RS, et al. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. J Biomol Struct Dyn. 2020 May 13;39(9):3244–55. Available from:
. - 6. Ogidigo JO, Iwuchukwu EA, Ibeji CU, Okpalefe O, Soliman MES. Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: Computational approach. J Biomol Struct Dyn. 2022 Mar 24;40(5):2284–301. Available from:
. - 7. Ramadhan DSF, Siharis F, Abdurrahman S, Isrul M, Fakih TM. In silico analysis of marine natural product from sponge (Clathria Sp.) for their activity as inhibitor of SARS-CoV-2 main protease. J Biomol Struct Dyn. 2022 Dec 12;40(22):11526–32. Available from:
. - 8. Zulkipli IN, Rajabalaya R, Idris A, Sulaiman NA, David SR. Clinacanthus nutans : A review on ethnomedicinal uses, chemical constituents and pharmacological properties. Pharm Biol. 2017 Jan 15;55(1):1093–113. Available from:
.
Details
Primary Language
English
Subjects
Natural Products and Bioactive Compounds, Biomolecular Modelling and Design
Journal Section
Research Article
Publication Date
September 10, 2026
Submission Date
November 9, 2025
Acceptance Date
August 8, 2026
Published in Issue
Year 2026 Volume: 2026 Number: 2
